Edward E. Lemmens

6.3k total citations · 4 hit papers
23 papers, 5.2k citations indexed

About

Edward E. Lemmens is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, Edward E. Lemmens has authored 23 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 7 papers in Oncology and 7 papers in Biotechnology. Recurrent topics in Edward E. Lemmens's work include Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (10 papers). Edward E. Lemmens is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (10 papers). Edward E. Lemmens collaborates with scholars based in United States and Netherlands. Edward E. Lemmens's co-authors include Stephen P. Schoenberger, Marianne J.B. van Stipdonk, Edith M. Janssen, Tom Wolfe, Matthias G. von Herrath, Urs Christen, Thomas W. Dubensky, Justin J. Leong, Kelsey E. Sivick and David B. Kanne and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Edward E. Lemmens

23 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

2003 1.3k citations Edith M. Janssen, Edward E. Lemmens et al. Nature profile →
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

2015 1.1k citations Leticia Corrales, Laura Hix Glickman et al. Cell Reports profile →
Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation

2001 726 citations Marianne J.B. van Stipdonk, Edward E. Lemmens et al. Nature Immunology profile →
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

2015 581 citations Juan Fu, David B. Kanne et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward E. Lemmens United States	16	4.5k	1.4k	1.3k	604	429	23	5.2k
Bjarne Bogen Norway	42	4.7k 1.0×	1.8k 1.3×	1.8k 1.4×	318 0.5×	613 1.4×	182	6.5k
Roger P.M. Sutmuller Netherlands	24	3.4k 0.8×	1.5k 1.1×	773 0.6×	361 0.6×	474 1.1×	30	4.5k
Tibor Keler United States	46	4.2k 0.9×	2.4k 1.7×	1.9k 1.5×	208 0.3×	325 0.8×	153	6.0k
Jean‐Pierre Abastado France	41	3.1k 0.7×	1.3k 1.0×	1.3k 1.0×	301 0.5×	572 1.3×	95	4.8k
Birthe Sauter United States	9	4.5k 1.0×	1.3k 1.0×	1.9k 1.5×	232 0.4×	413 1.0×	10	5.6k
Scott A. Hammond United States	34	2.1k 0.5×	1.7k 1.2×	753 0.6×	230 0.4×	465 1.1×	82	3.8k
Jens Dannull United States	24	2.9k 0.6×	1.5k 1.1×	1.8k 1.4×	251 0.4×	206 0.5×	48	4.0k
Amanda L. Marzo United States	28	4.1k 0.9×	1.1k 0.8×	562 0.4×	219 0.4×	483 1.1×	51	4.9k
Carlo Heirman Belgium	47	4.8k 1.1×	2.2k 1.6×	3.2k 2.5×	318 0.5×	362 0.8×	118	6.7k
Dirk G. Brockstedt United States	29	3.5k 0.8×	2.0k 1.4×	1.3k 1.0×	230 0.4×	315 0.7×	77	5.0k

Countries citing papers authored by Edward E. Lemmens

Since Specialization

Citations

This map shows the geographic impact of Edward E. Lemmens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward E. Lemmens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward E. Lemmens more than expected).

Fields of papers citing papers by Edward E. Lemmens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward E. Lemmens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward E. Lemmens. The network helps show where Edward E. Lemmens may publish in the future.

Co-authorship network of co-authors of Edward E. Lemmens

This figure shows the co-authorship network connecting the top 25 collaborators of Edward E. Lemmens. A scholar is included among the top collaborators of Edward E. Lemmens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward E. Lemmens. Edward E. Lemmens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lemmens, Edward E., Weiqun Liu, Justin Skoble, et al.. (2019). A Potent and Effective SuicidalListeriaVaccine Platform. Infection and Immunity. 87(8). 12 indexed citations

Deng, Weiwen, Thomas E. Hudson, Edward E. Lemmens, et al.. (2018). Recombinant Listeria promotes tumor rejection by CD8 ⁺ T cell-dependent remodeling of the tumor microenvironment. Proceedings of the National Academy of Sciences. 115(32). 8179–8184. 70 indexed citations

Corrales, Leticia, Laura Hix Glickman, Sarah M. McWhirter, et al.. (2015). Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Reports. 11(7). 1018–1030. 1146 indexed citations breakdown →

Fu, Juan, David B. Kanne, Meredith L. Leong, et al.. (2015). STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Science Translational Medicine. 7(283). 283ra52–283ra52. 581 indexed citations breakdown →

Corrales, Leticia, Laura Hix Glickman, Sarah M. McWhirter, et al.. (2014). Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations

Dubensky, Thomas W., Meredith L. Leong, David B. Kanne, et al.. (2013). Abstract 4573: STINGVAX - A novel tumor vaccine with cyclic dinucleotides - can induce potent anti-tumor responses in vivo.. Cancer Research. 73(8_Supplement). 4573–4573. 2 indexed citations

Bahjat, Keith S., Nicole Meyer-Morse, Edward E. Lemmens, et al.. (2009). Suppression of Cell-Mediated Immunity following Recognition of Phagosome-Confined Bacteria. PLoS Pathogens. 5(9). e1000568–e1000568. 27 indexed citations

Škoberne, Mojca, Alice Yewdall, Keith S. Bahjat, et al.. (2008). KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. Journal of Clinical Investigation. 118(12). 3990–4001. 35 indexed citations

Škoberne, Mojca, Alice Yewdall, Keith S. Bahjat, et al.. (2008). Use of KBMA Listeria monocytogenes as an antigen loading platform for dendritic cell-mediated induction of antitumor immunity. Journal of Clinical Oncology. 26(15_suppl). 3044–3044. 1 indexed citations

10.

Bahjat, Keith S., Rodney A. Prell, Heather E. Allen, et al.. (2007). Activation of Immature Hepatic NK Cells As Immunotherapy for Liver Metastatic Disease. The Journal of Immunology. 179(11). 7376–7384. 21 indexed citations

11.

Brockstedt, Dirk G., Meredith L. Leong, Keith S. Bahjat, et al.. (2007). Live-attenuated L. monocytogenes encoding mesothelin for immunotherapy of patients with pancreas and ovarian cancers. 67. 1874–1874. 3 indexed citations

12.

Spierings, Diana C.J., et al.. (2006). Duration of CTL activation regulates IL‐2 production required for autonomous clonal expansion. European Journal of Immunology. 36(7). 1707–1717. 17 indexed citations

13.

Bahjat, Keith S., Weiqun Liu, Edward E. Lemmens, et al.. (2006). Cytosolic Entry Controls CD8⁺-T-Cell Potency during Bacterial Infection. Infection and Immunity. 74(11). 6387–6397. 52 indexed citations

14.

Janssen, Edith M., Nathalie Droin, Edward E. Lemmens, et al.. (2005). CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature. 434(7029). 88–93. 490 indexed citations

15.

Kurz, Sabine, Edward E. Lemmens, Stephen P. Schoenberger, et al.. (2004). IL-7 regulates basal homeostatic proliferation of antiviral CD4 ⁺ T cell memory. Proceedings of the National Academy of Sciences. 101(25). 9357–9362. 161 indexed citations

16.

Janssen, Edith M., Edward E. Lemmens, Tom Wolfe, et al.. (2003). CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature. 421(6925). 852–856. 1314 indexed citations breakdown →

17.

Stipdonk, Marianne J.B. van, Gijs Hardenberg, Martijn S. Bijker, et al.. (2003). Dynamic programming of CD8+ T lymphocyte responses. Nature Immunology. 4(4). 361–365. 333 indexed citations

18.

Prilliman, Kiley R., et al.. (2002). Cutting Edge: A Crucial Role for B7-CD28 in Transmitting T Help from APC to CTL. The Journal of Immunology. 169(10). 6056–6056. 4 indexed citations

19.

Prilliman, Kiley R., et al.. (2002). Cutting Edge: A Crucial Role for B7-CD28 in Transmitting T Help from APC to CTL. The Journal of Immunology. 169(8). 4094–4097. 45 indexed citations

20.

Stipdonk, Marianne J.B. van, Edward E. Lemmens, & Stephen P. Schoenberger. (2001). Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nature Immunology. 2(5). 423–429. 726 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact